-
Je něco špatně v tomto záznamu ?
Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database study
R. Kubeš, M. Stollin, Š. Magersky, M. Bobelyak, J. Vaculík, J. Včelák, A. Antonín Kuběna, J. Loužil, P. Salaj
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- hemartróza diagnóza etiologie MeSH
- hemofilie A * komplikace MeSH
- kolenní kloub MeSH
- lidé středního věku MeSH
- lidé MeSH
- loketní kloub * MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Patients with hemophilia (PWH) develop hemophilic arthropathy of the major joints due to recurrent hemarthrosis. This study retrospectively estimated the age at which PWH may expect to develop hemophilic arthropathy and undergo joint replacement surgery. RESEARCH DESIGN AND METHODS: Using retrospective data from PWH at a Czech orthopedic center, Kaplan Meier analyses were used to estimate the cumulative proportions of patients with hemophilic arthropathy and undergoing joint replacement surgery as a function of age. RESULTS: Based on 1028 joint examinations in 167 PWH, hemophilic arthropathy of the knees, elbows, ankles and hips was estimated to develop by a median age of 48, 51, 52 and 61 years, respectively, with ≈80% of patients having such damage by ≈70 years of age. Hemophilic arthropathy of the shoulder occurred much later (median >80 years). In patients undergoing knee or hip replacement surgery, hemophilic arthropathy of the knee and hip occurred at a median age of ≈50 and ≈60 years, respectively, with replacement surgery occurring at a median of ≈70 and >75 years. CONCLUSIONS: In PWH, the risk of developing hemophilic arthropathy accumulates continuously over the patient's lifetime, allowing predictions about the ages at which such damage and joint replacement surgery may occur.
Department of Orthopaedics 1st Faculty of Medicine Charles University Prague 8 Czech Republic
Transfusiological Division Institute of Hematology and Blood Transfusion Prague 2 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001289
- 003
- CZ-PrNML
- 005
- 20241014101517.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/17474086.2023.2289536 $2 doi
- 035 __
- $a (PubMed)38015035
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kubeš, Radovan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 245 10
- $a Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database study / $c R. Kubeš, M. Stollin, Š. Magersky, M. Bobelyak, J. Vaculík, J. Včelák, A. Antonín Kuběna, J. Loužil, P. Salaj
- 520 9_
- $a BACKGROUND: Patients with hemophilia (PWH) develop hemophilic arthropathy of the major joints due to recurrent hemarthrosis. This study retrospectively estimated the age at which PWH may expect to develop hemophilic arthropathy and undergo joint replacement surgery. RESEARCH DESIGN AND METHODS: Using retrospective data from PWH at a Czech orthopedic center, Kaplan Meier analyses were used to estimate the cumulative proportions of patients with hemophilic arthropathy and undergoing joint replacement surgery as a function of age. RESULTS: Based on 1028 joint examinations in 167 PWH, hemophilic arthropathy of the knees, elbows, ankles and hips was estimated to develop by a median age of 48, 51, 52 and 61 years, respectively, with ≈80% of patients having such damage by ≈70 years of age. Hemophilic arthropathy of the shoulder occurred much later (median >80 years). In patients undergoing knee or hip replacement surgery, hemophilic arthropathy of the knee and hip occurred at a median age of ≈50 and ≈60 years, respectively, with replacement surgery occurring at a median of ≈70 and >75 years. CONCLUSIONS: In PWH, the risk of developing hemophilic arthropathy accumulates continuously over the patient's lifetime, allowing predictions about the ages at which such damage and joint replacement surgery may occur.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a hemofilie A $x komplikace $7 D006467
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hemartróza $x diagnóza $x etiologie $7 D006395
- 650 _2
- $a kolenní kloub $7 D007719
- 650 12
- $a loketní kloub $7 D004551
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Stollin, Martin $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 700 1_
- $a Magersky, Štěpán $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 700 1_
- $a Bobelyak, Maryan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 700 1_
- $a Vaculík, Jan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 700 1_
- $a Včelák, Josef $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
- 700 1_
- $a Antonín Kuběna, Aleš $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Loužil, Jan, $u Transfusiological Division, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic $d 1980- $7 xx0324132
- 700 1_
- $a Salaj, Peter $u Centre for Thrombosis and Hemostasis, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
- 773 0_
- $w MED00174419 $t Expert review of hematology $x 1747-4094 $g Roč. 16, č. 12 (2023), s. 1099-1105
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38015035 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20241014101515 $b ABA008
- 999 __
- $a ok $b bmc $g 2049736 $s 1210983
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 16 $c 12 $d 1099-1105 $e 20231218 $i 1747-4094 $m Expert review of hematology $n Expert Rev Hematol $x MED00174419
- LZP __
- $a Pubmed-20240109